| Bio-Link News |
|
19/09/2018 – Australia’s back yard science challenges the pharma industry with ‘home-brew’ insulin…more. 14/09/2018 – Dr Daniella Goldberg has joined the Bio-Link team in the role of PR and Communications Manager…more. 10/09/2018 – Christopher Boyer’s recent presentation on de-risking preclinical assets with early human insights is available…here. |
| Client News |
|
25/05/2018 – Actinogen Medical announce a positive DSMB interim analysis of ph II Alzheimer’s trial and a major $15M placement…more 01/05/2018 – Congratulations to our client, CMRI, for receiving an additional $41 million for the ProCan project…see post. 26/04/2018 – Prof Maria Kavallaris and her team at CCI have published new findings about microtubule domain structures…more |
| Industry News |
| Welcome to Bio-Link |
|
Bio-Link is a strategic consulting and biotechnology business development company that works with Australian and international life sciences companies and academic institutions to facilitate deals based on strategic technology analysis and consulting, business development, project management and deal negotiation. Bio-Link also provides technology scouting and representation services for Australian and international companies. Bio-Link has offices in Melbourne and Sydney. Please explore our website to learn more about Bio-Link’s services and client endorsements and our portfolio of client technologies. Follow @BioLinkAus |
Bio-Link employs BDcrowd™ and Medtrack Pharma Intelligence software to execute on business development
|
Bio-Link is a proud member of
|
